Latest Breaking News On - Akebia therapeutics inc - Page 7 : comparemela.com

Investment Analysts Price Target Changes for March 28th (AKBA, ALLY, AROC, ATEC, AXP, AXSM, BAC, BRZE, BWXT, CCL)

Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […]

United statesRoth mkmPiper sandlerMoffett nathansonStifel nicolausRobertw bairdEvolent healthEducation technology groupOppenheimer holdings incHealth servicesCitigroup incHighwoods propertiesDeutsche bank aktiengesellschaftBarrington researchUs bancorpCarnival co

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday - Cintas (NASDAQ:CTAS), Noah Holdings (NYSE:NOAH), PaySign (NASDAQ:PAYS)

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Ew scripps companyNovocure limitedCintas corporationSemtech corporationKohl corporationAkebia therapeutics incMerck co incSafflower holdingsMarvell technology incLexicon pharmaceuticals incNoah holdings limitedCino incAnnexon incTrump media technology group corpGroup hospitality incDow jones

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAkebia therapeutics incDrug administrationDrug user fee act

Akebia Therapeutics To Report Fourth Quarter And Full Year 2023 Financial Results

Akebia Therapeutics To Report Fourth Quarter And Full Year 2023 Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMercedes carrascoAkebia therapeutics incDrug administrationDrug user fee act

Insider Selling: Akebia Therapeutics, Inc (NASDAQ:AKBA) SVP Sells 24,311 Shares of Stock

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) SVP Steven Keith Burke sold 24,311 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $1.68, for a total transaction of $40,842.48. Following the completion of the sale, the senior vice president now owns 711,376 […]

Steven keith burkeAkebia therapeutics incMirabella financial servicesArcher investment corpMackenzie financial corpRaymond james associatesAkebia therapeuticsGet free reportKeith burkeTherapeutics trading downInvestment corpFinancial corpAkebia therapeutics dailyNasdaq akbaInsider tradingNsider trades